Simpson Thacher & Bartlett represented CM Hospitalar S.A. (“Viveo”) in the offering. CM Hospitalar S.A. (“Viveo”) announced the follow-on offering of R$1.2 billion (approximately USD$245 million) aggregate principal...
Viveo’s R$1.2 Billion Follow-On Offering of Common Shares
Viveo’s $50 Million Acquisition of Profusion
Pinheiro Neto Advogados advised Viveo on the transaction. Barbosa, Müssnich, Aragão Advogados and Coelho & Dalle Advogados represented Vinci Partners. VDV Advogados advised Profusion Funders. Brazilian...
Viveo’s Acquisition of FAMAP
Demarest advised Viveo on the deal Viveo executed the acquisition of FAMAP. FAMAP is a pharmaceutical company that develops parenteral and enteral nutrition products. Viveo is a healthcare technology...
Viveo’s Acquisition of Hospshop
Demarest Advised Viveo on the transaction Viveo executed the acquisition of Hospshop. Hospshop Medical Eireli is an enterprise based in Brazil. Its main office is in Manaus....
Viveo’s Acquisition of Laboratorio de Insumos Farmacêuticos Estéreis
Demarest advised Viveo on the deal Viveo executed the Acquisition of Laboratorio de Insumos Farmacêuticos Estéreis Viveo is a healthcare technology platform that unites the entire health ecosystem...
Viveo’s acquisition of Laborsys
Pinheiro Guimarães advised Viveo (CM Hospitalar S.A.) on the transaction. Boccuzzi Advogados advised Laborsys Produtos Diagnósticos selling shareholders. Viveo (CM Hospitalar S.A.) executed the acquisition of Laborsys...